Sage Therapeutics, Inc.
A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID

Last updated:

Abstract:

This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), ##STR00001## and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.

Status:
Application
Type:

Utility

Filling date:

6 Aug 2021

Issue date:

2 Jun 2022